Benchmark Electronics to Handle Manufacturing of Rapid COVID-19 Test System

by Benchmark / September 23, 2020

Benchmark Electronics, Inc. (NYSE:BHE), a global provider of engineering, design, and manufacturing services, and consumer genetic testing pioneers DnaNudge, today announced a key manufacturing partnership to deliver volume production of DnaNudge's rapid, lab-free reverse transcription polymerase chain reaction (RT-PCR) COVID-19 testing system. DnaNudge's ground-breaking consumer DNA testing innovation, which requires no lab and delivers results in just over an hour, has been re-engineered as a testing system to accurately detect COVID-19. In August, the U.K. government announced an order for 5.8 million CovidNudge testing kits to be rolled out in NHS hospitals and out-of-hospital locations across the U.K. starting September 2020, following successful validation.

Read the full article on Bloomberg Business

Benchmark's Herman Bartelink had the opportunity to showcase the new DnaNudge CovidNudge manufacturing line with Dutch television news segment EénVandaag.

Watch the video with English subtitles

To view the original story in Dutch, visit NPO's website here.

To learn more about DnaNudge and their rapid testing system, visit their website.

Manufacturing Medical News

about the author


Benchmark is a global product realization services company with unique capabilities in aerospace, defense, complex industrials, semiconductor capital equipment, next-gen communications, advanced computing, and medical technologies. Our services support your innovative products, from concept through volume production, with design engineering, precision machining, full-system electronic assembly, and lifecycle management.

up-to-date content